Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604] (EBioMedicine (2020) 51, (S2352396419308199), (10.1016/j.ebiom.2019.102604))

Zhaolai Qi, Ting Zhang, Lei Song, Hongyong Fu, Haifeng Luo, Jie Wu, Shuyun Zhao, Tianhua Zhang, Lianying Guo, Lingling Jin, He Zhang, Gena Huang, Tonghui Ma, Yingjie Wu, Lin Huang

Research output: Contribution to journalComment/debate


The authors regret that the published version of this article contained errors in Figs. 4d, 7 a and 7e. For the β-actin loading control in Fig. 4d (right panel), an extra band next to the sample shPRAS40 1 was included by mistake; there should be 7 lanes instead of 8 lanes. We realized the original western blot data for Fig. 7a had been misplaced, while the original western blot data obtained from two repeated and concordant experiments were present. To ensure data accuracy, we therefore substituted Fig. 7a with data from a replicated experiment. After investigating all the original data of Fig. 7e, we found that parts of images from PRAS40+nc and PRAS40+miR-124-3p were identical. We realized the names of these original images had been inadvertently wrongly labeled. The corrected figures are given below. These corrections have not changed the description, interpretation, or the conclusions of the manuscript in the originally published version. The authors apologize for any inconvenience caused.

Original languageEnglish
Article number103001
StatePublished - Oct 2020


Dive into the research topics of 'Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604] (EBioMedicine (2020) 51, (S2352396419308199), (10.1016/j.ebiom.2019.102604))'. Together they form a unique fingerprint.

Cite this